Becton Dickinson (NYSE:BDX) said this week it will spend $8 million to upgrade emissions controls at two medical device sterilization plants it operates in Georgia.
The plants in Covington and Madison, Ga., both southeast of Atlanta, use ethylene oxide (EO) to sterilize medical devices. The federal Environmental Protection Agency recognizes EO as a carcinogen and lowered its limits on emissions of the sterilant gas in 2016. BD acquired the plants when it bought C.R. Bard in 2017.
Get the full story on our sister site, Medical Design & Outsourcing.